BSE filing, NSE: ARTEMISMED. Summary written from the filing by ALFA Finder's alert engine.
Artemis Medicare Services Ltd: key numbers
- Share price
- ₹297.45
- Market cap
- ₹4,709 Cr
- Revenue (annual)
- ₹1,081 Cr
- Net profit (annual)
- ₹103.6 Cr
- P/E (TTM)
- 41.4×Sector 52.0×
- Promoter holding
- 58.39%+0.00% QoQ
- FII holding
- 12.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Artemis Medicare Services Ltd
All →Artemis Medicare Services Board Meeting Date
Artemis Medicare scheduled a board meeting for Oct 30, 2026 to approve Q1 un-audited results. Trading window remains closed until Nov 1, 2026.
Artemis Medicare Services Other Announcement
Artemis Medicare Services Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI regulatory requirements.
Artemis Medicare Services Legal & Regulatory
Artemis Medicare received a Rs. 11.11 Crore Show Cause Notice from the GST department. The company is contesting this through a writ petition.
- Value
- ₹11.11 Cr
Artemis Medicare Services Credit Rating
CARE Ratings reaffirmed Artemis Medicare's bank facility ratings at CARE A with Stable outlook. Long-term and short-term facilities totalling ₹388.15 Cr were reviewed.
Artemis Medicare Services Earnings Call Transcript: Key Takeaways
Artemis reports strong Q1 FY27 growth, driven by Gurgaon performance and the Raipur hospital launch. Management is pivoting toward high-end quaternary care with a massive 2,000-bed expansion target by 2030.
Artemis Medicare Services Capacity Expansion: ₹180 Cr Investment
Artemis Medicare Services will invest ₹180 Crore to add 200+ beds at its Gurugram hospital, focusing on pediatric and gynecological services.
- Value
- ₹180.0 Cr
- Execution
- ~ 2 years
Other board meeting date announcements
All →Radhika Jeweltech Board Meeting Date
Radhika Jeweltech will hold a board meeting on November 3, 2026 to consider unaudited quarterly results. The trading window reopens 48 hours after results are declared.
Technopack Polymers Board Meeting Date
Technopack Polymers will hold a board meeting on 4 November 2026 to consider unaudited standalone results for the half year ended 30 September 2026. Trading window closes from 1 October 2026 until 48 hours after the results are made public.
Shlokka Dyes Board Meeting Date
Shlokka Dyes scheduled a board meeting for November 3, 2026 to consider half-year results and fund-raising. Agenda items are proposed and subject to approvals.
Trom Industries Board Meeting Date
TROM Industries Limited has scheduled a board meeting on 03-Nov-2026 to consider unaudited half-yearly standalone results for the period ended September 2026. The trading window closes from 01-Oct-2026 until 05-Nov-2026.
Archit Organosys Board Meeting Date
Archit Organosys will hold a board meeting on November 4, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window has been closed since October 1, 2026.
Ovobel Foods Board Meeting Date
Ovobel Foods will hold a board meeting on November 6, 2026 to consider unaudited results for the quarter ended September 2026. The trading window stays closed until 48 hours after the results announcement.